This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Security News Highlights 07/01/2014
Share This:(TSPT) (FOLD) (TWTR) Higher; (APP) (GEVA) (GNRC) Lower (more…) 9:34 AM ET, 07/01/2014 – Street Insider Transcept Pharma (Nasdaq: TSPT) 23.6% HIGHER; Transcept Pharma and Paratek Pharmaceuticals, Inc., a privately-held biopharmaceutical company, announced that they have entered into a definitive merger agreement under which the stockholders of Paratek will become the majority owners of Transcept and the operations of Transcept and Paratek will be combined. As part of the proposed transaction, new investors (including The Baupost Group, Abingworth LLP, and other institutional investors); certain Transcept stockholders (including InterWest Ventures and Roumell Asset Management); and certain Paratek stockholders (including Omega
Bookmark the permalink.